ARTICLE | Clinical News
Comfyde carisbamate regulatory update
February 1, 2010 8:00 AM UTC
Johnson & Johnson's Janssen-Cilag Ltd. unit said it withdrew an MAA for Comfyde carisbamate for the adjunctive treatment of partial onset seizures in patients 16 and older. The company said it withdre...